Preparation, physicochemical characterization, and in vitro and in vivo osteogenic evaluation of a bioresorbable, moldable, hydroxyapatite/poly(caprolactone-co-lactide) bone substitute

被引:4
|
作者
Wu, Yuhan [1 ,2 ]
Zeng, Wenyi [1 ,2 ]
Xu, Jiayun [1 ,2 ]
Sun, Yang [3 ]
Huang, Yucheng [3 ]
Xiang, Dong [3 ]
Zhang, Chenguang [1 ,2 ]
Fu, Zheng [1 ,2 ]
Deng, Feilong [1 ,2 ]
Yu, Dongsheng [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Guangzhou 510055, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou, Peoples R China
[3] Shenzhen Corliber Regenerat Mat Lab, Dept Dent Implant, Shenzhen, Peoples R China
关键词
bioactivity evaluation; bioresorbable; bone substitute; hydroxyapatite; poly (caprolactone-co-lactide); AUGMENTATION; IMPLANTS; CELLS;
D O I
10.1002/jbm.a.37463
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Use of bioresorbable artificial bone substitutes is anticipated for bone augmentation in dental implant surgery because they are relatively economical and uniform in quality compared to heterogeneous bone. In this study, a new shapable, rubbery, bioresorbable bone substitute was developed. The material was prepared by ultrasonically dispersing hydroxyapatite (HA) particles throughout a poly (caprolactone-co-lactide) (PCLLA) rubbery matrix. Physiochemical properties of the bone substitute including its composition, deformability, anti-collapse ability, degradation behavior, and in vitro and in vivo osteogenic ability were evaluated. Results revealed that HA/PCLLA, which consists of homogeneously dispersed HA particles and a rubbery matrix composed of PCLLA, possesses a deformable capacity. The result of the mass retention rate of the material indicated an excellent durability in an aqueous environment. Further, the effects of HA/PCLLA on cell functions and bone-regenerated performance were evaluated in vitro and in vivo. The results showed that HA/PCLLA had enhanced proliferative capacity, and ability to undergo osteogenic differentiation and mineralization in vitro. It was also found that HA/PCLLA had an appropriate degradation rate to induce consecutive new bone formation without collapse at the early stage in vivo, as well as the ability to maintain the contour of the bone-grafting area, which is comparable to the deproteinized bovine bone mineral. These results indicated that HA/PCLLA is a promising bioresorbable bone substitute with properties that meet clinical requirements, including deformability, resistance to collapse in an aqueous environment, appropriate early-stage degradation rate, biocompatibility, osteogenic bioactivity and the capacity to regenerate bone tissue with favorable contour.
引用
收藏
页码:367 / 377
页数:11
相关论文
共 50 条
  • [21] Preparation and In-vitro Degradation Behavior of Poly(L-lactide-co-glycolide-co-ε-caprolactone) Terpolymer
    Wu, Wei
    Zhou, Zhihua
    Liu, Wenjuan
    Zhao, Yunhui
    Zhao, Yanmin
    Huang, Tianlong
    Li, Xiaofei
    Fang, Jianjun
    JOURNAL OF MACROMOLECULAR SCIENCE PART B-PHYSICS, 2019, 58 (05): : 568 - 577
  • [22] Preparation and characterization of blends of star-poly(ε-caprolactone-co-D,L-lactide) and oligo(ε-caprolactone)
    Tomkins, A
    Kontopoulou, M
    Amsden, B
    JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2005, 16 (08) : 1009 - 1021
  • [23] In vivo evaluation of a porous hydroxyapatite/poly-D-lactide composite for bone tissue engineering
    Hasegawa, Shin
    Neo, Masashi
    Tamura, Jiro
    Fujibayashi, Shunsuke
    Takemoto, Mitsuru
    Shikinami, Yasuo
    Okazaki, Kenshi
    Nakamura, Takashi
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2007, 81A (04) : 930 - 938
  • [24] Poly-ε-caprolactone/hydroxyapatite composites for bone regeneration:: in vitro characterization and human osteoblast response
    Causa, F
    Netti, PA
    Ambrosio, L
    Ciapetti, G
    Baldini, N
    Pagani, S
    Martini, D
    Giunti, A
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 76A (01) : 151 - 162
  • [25] Embroidered and Surface Modified Polycaprolactone-Co-Lactide Scaffolds as Bone Substitute: In Vitro Characterization
    Rentsch, Barbe
    Hofmann, Andre
    Breier, Annette
    Rentsch, Claudia
    Scharnweber, Dieter
    ANNALS OF BIOMEDICAL ENGINEERING, 2009, 37 (10) : 2118 - 2128
  • [26] Embroidered and Surface Modified Polycaprolactone-Co-Lactide Scaffolds as Bone Substitute: In Vitro Characterization
    Barbe Rentsch
    Andre Hofmann
    Annette Breier
    Claudia Rentsch
    Dieter Scharnweber
    Annals of Biomedical Engineering, 2009, 37 : 2118 - 2128
  • [27] Preparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticles
    Rodrigues, Mainara Rangel
    Lanzarini, Cintia Maria
    Ricci-Junior, Eduardo
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2011, 16 (01) : 12 - 21
  • [28] In Vitro and In Vivo Evaluations of Bioactive Poly(ε-caprolactone)-Organosiloxane Nano-Hybrid Developed as a Novel Bone Substitute
    Yoo, J. J.
    Kim, H. J.
    Rhee, S-H.
    NSTI NANOTECH 2008, VOL 2, TECHNICAL PROCEEDINGS: LIFE SCIENCES, MEDICINE, AND BIO MATERIALS, 2008, : 314 - 317
  • [29] Preparation of methoxy poly (ethyleneglycol)-b-poly (ε-caprolactone-co-L-lactide) and characterization as biodegradable micelles
    Kwon, Doo Yeon
    Tai, Guo Zhe
    Park, Ji Hoon
    Lee, Bo Keun
    Lee, Jae Hyeok
    Kim, Jae Ho
    Lee, Kyu Wan
    Lee, Bong
    Jang, Ju Woong
    Kim, Moon Suk
    JOURNAL OF POLYMER RESEARCH, 2014, 21 (06)
  • [30] Evaluation of the in vitro cytotoxicity and modulation of the inflammatory response by the bioresorbable polymers poly(D,L-lactide-co-glycolide) and poly(L-lactide-co-glycolide)
    Geddes, Lucy
    Themistou, Efrosyni
    Burrows, James F.
    Buchanan, Fraser J.
    Carson, Louise
    ACTA BIOMATERIALIA, 2021, 134 (134) : 261 - 275